Tomita Y - Search Results

1

Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma.

Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y. Saito T, et al. Among authors: tomita y. Br J Cancer. 1996 Feb;73(3):327-31. doi: 10.1038/bjc.1996.57. Br J Cancer. 1996. PMID: 8562338 Free PMC article.

2

Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer.

Katagiri A, Tomita Y, Nishiyama T, Kimura M, Sato S. Katagiri A, et al. Among authors: tomita y. Br J Cancer. 1993 Jul;68(1):125-9. doi: 10.1038/bjc.1993.299. Br J Cancer. 1993. PMID: 8100442 Free PMC article.

3

Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.

Wakatsuki S, Watanabe R, Saito K, Saito T, Katagiri A, Sato S, Tomita Y. Wakatsuki S, et al. Among authors: tomita y. Cancer Lett. 1996 May 15;103(1):11-7. doi: 10.1016/0304-3835(96)04194-8. Cancer Lett. 1996. PMID: 8616803

4

MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.

Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y. Saito T, et al. Among authors: tomita y. Cancer Lett. 1996 Dec 3;109(1-2):15-21. doi: 10.1016/s0304-3835(96)04395-9. Cancer Lett. 1996. Corrected and republished in: Cancer Lett. 1997 May 1;115(1):121-7. doi: 10.1016/s0304-3835(97)04754-x PMID: 9020898 Corrected and republished.

5

MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.

Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y. Saito T, et al. Among authors: tomita y. Cancer Lett. 1997 May 1;115(1):121-7. doi: 10.1016/s0304-3835(97)04754-x. Cancer Lett. 1997. PMID: 9097987

6

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.

Bilim VN, Tomita Y, Kawasaki T, Takeda M, Takahashi K. Bilim VN, et al. Among authors: tomita y. Cancer Lett. 1998 Jun 5;128(1):87-92. doi: 10.1016/s0304-3835(98)00055-x. Cancer Lett. 1998. PMID: 9652797

7

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.

Kimura M, Tomita Y, Imai T, Saito T, Katagiri A, Tanikawa T, Takeda M, Takahashi K. Kimura M, et al. Among authors: tomita y. Br J Cancer. 1999 Jul;80(10):1648-51. doi: 10.1038/sj.bjc.6690576. Br J Cancer. 1999. PMID: 10408413 Free PMC article.

8

Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.

Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y. Bilim V, et al. Among authors: tomita y. Clin Cancer Res. 2000 Feb;6(2):460-6. Clin Cancer Res. 2000. PMID: 10690524

9

Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.

Bilim V, Kawasaki T, Takahashi K, Tomita Y. Bilim V, et al. Among authors: tomita y. J Exp Clin Cancer Res. 2000 Dec;19(4):483-8. J Exp Clin Cancer Res. 2000. PMID: 11277327

10

Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy.

Hara N, Kasahara T, Kawasaki T, Bilim V, Tomita Y, Obara K, Takahashi K. Hara N, et al. Among authors: tomita y. Br J Cancer. 2001 Aug 17;85(4):557-62. doi: 10.1054/bjoc.2001.1924. Br J Cancer. 2001. PMID: 11506496 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,547 results

Search Page

Filters